BESIFLOXACIN HYDROCHLORIDE
| Brand name | BESIVANCE |
|---|---|
| Active ingredient | BESIFLOXACIN HYDROCHLORIDE |
| Strength | EQ 0.6% BASE |
| Dosage form | SUSPENSION/DROPS |
| Route | OPHTHALMIC |
| Modality | Small molecule |
| FDA approval | May 2009 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 8481526 | January 2031 | substance |
| 8415342 | November 2030 | use U-80 |
| 8604020 | March 2030 | product |
| 8937062 | November 2029 | use U-80 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.